Menu

CERo Therapeutics (NASDAQ: CERO) denied over $2.5M equity rule; suspended Oct. 31

Article |

BorealOSA68 2mo ago
CERo Therapeutics (NASDAQ: CERO) denied over $2.5M equity rule; suspended Oct. 31

Nasdaq Panel denies CERo's continued listing; trading suspended Oct 31. Company seeks Council review, pursues OTC, and reports $2.25M closed...

Comments (0)

Newest

No comments yet.